Cochlear Implants Overcome Resistance
When the FDA approved cochlear implants for adults in 1984 and children in 1990, many in the Deaf community opposed them as cultural genocide—attempting to 'fix' deaf people rather than accepting deafness as a natural variation. The National Association of the Deaf initially opposed pediatric cochlear implantation. Parents faced difficult choices between medical intervention and Deaf culture. Over time, outcomes data showed clear benefits for early implantation, particularly for speech and language development.
Adoption grew slowly amid fierce cultural debates, with many Deaf leaders viewing implants as threats to sign language communities.
Cochlear implants became standard of care for severe-to-profound hearing loss, with 736,900 devices implanted globally by 2019. Deaf community adapted, many embracing both technological intervention and cultural identity.
Gene therapy reignites the same cultural tensions cochlear implants faced: Is deafness a disability to cure or a difference to celebrate? Early intervention raises stakes even higher, as gene therapy in infancy could prevent children from ever entering Deaf culture.